FAP显像在罕见肿瘤中的首次临床经验:广谱恶性肿瘤回顾性分析
该回顾性分析纳入55例罕见肿瘤患者(患病率≤1/2000),行68Ga-FAPI-PET/CT显像。20/55例识别原发灶,31例呈现转移灶(n=88),原发灶平均SUVmax 10.1、转移灶7.6;腹膜癌平均SUVmax 9.8、TBR 29.6,肝转移平均SUVmax 9.8、TBR 8.7。结论认为68Ga-FAPI-PET/CT对罕见恶性肿瘤(尤其上皮癌)显像对比度高,可作为标准诊断影像的补充。
要点
- 55例罕见肿瘤中20例FAPI-PET/CT识别原发灶,31例显示转移灶。
- 原发灶平均SUVmax 10.1,转移灶平均SUVmax 7.6。
- 腹膜癌TBR达29.6,肝转移TBR 8.7,肿瘤对比度高。
核心结论
- 68Ga-FAPI-PET/CT在罕见恶性肿瘤(尤其上皮癌)中原发与转移灶显像对比度高,可作为标准诊断影像的补充。
研究设计与样本
- 患者行68Ga-FAPI-PET/CT扫描,按肿瘤亚组分为原发不明癌(n=10)、头颈癌(n=13)、胃肠及胆胰癌(n=17)、泌尿道癌(n=4)、神经内分泌癌(n=4)及其他(n=7)。
- 示踪剂摄取以SUVmax和SUVmean量化,并计算肿瘤/本底比值(TBR,肿瘤SUVmax/器官SUVmean)。
主要发现
- 55例中20例识别原发肿瘤,31例呈现转移灶(n=88),原发灶平均SUVmax 10.1、转移灶平均SUVmax 7.6。
- 肝转移(n=6)平均SUVmax 9.8、TBR 8.7;腹膜癌(n=16)平均SUVmax 9.8、TBR 29.6。
- 亚组中胃肠及胆胰癌平均SUVmax最高为9.8,其次泌尿道癌9.5、头颈癌9.1。
临床怎么用
- 对罕见肿瘤(尤其上皮癌)可考虑68Ga-FAPI-PET/CT辅助识别原发灶与转移灶,作为标准诊断影像的补充。
局限性
- 为回顾性分析,样本量55例且亚组例数少,结论需前瞻性研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: 68 Ga-FAPI (fibroblast activation protein inhibitor) is a rapidly evolving and highly promising radiotracer for PET/CT imaging, presenting excellent results in a variety of tumor entities, particularly in epithelial carcinomas. This retrospective analysis sought to evaluate the potential and impact of FAPI-PET/CT in rare cancer diseases with respect to improvement in staging and therapy, based on tracer uptake in normal organs and tumors. MATERIAL AND METHODS: Fifty-five patients with rare tumor entities, defined by a prevalence of 1 person out of 2000 or less, received a 68 Ga-FAPI-PET/CT scan. Fourteen women and 41 men (median age 60) were included within the following subgroups: cancer of unknown primary (n = 10), head and neck cancer (n = 13), gastrointestinal and biliary-pancreatic cancer (n = 17), urinary tract cancer (n = 4), neuroendocrine cancer (n = 4), and others (n = 7). Tracer uptake was quantified by standardized uptake values SUVmax and SUVmean and the tumor-to-background ratio (TBR) was determined (SUVmax tumor/SUVmean organ). RESULTS: In 20 out of 55 patients, the primary tumor was identified and 31 patients presented metastases (n = 88), characterized by a high mean SUVmax in primary (10.1) and metastatic lesions (7.6). The highest uptake was observed in liver metastases (n = 6) with a mean SUVmax of 9.8 and a high TBR of 8.7, closely followed by peritoneal carcinomatosis (n = 16) presenting a mean SUVmax of 9.8 and an excellent TBR of 29.6. In terms of the included subgroups, the highest uptake regarding mean SUVmax was determined in gastrointestinal and biliary-pancreatic cancer with 9.8 followed closely by urinary tract cancer with 9.5 and head and neck cancer (9.1). CONCLUSION: Due to excellent tumor visualization and, thereby, sharp contrasts in terms of high TBRs in primary and metastatic lesions in different rare malignancies, 68 Ga-FAPI-PET/CT crystallizes as a powerful and valuable imaging tool, particularly with respect to epithelial carcinomas, and therefore an enhancement to standard diagnostics imaging methodologies. The realization of further and prospective studies is of large importance to confirm the potential of FAP imaging in oncology.
引用
- Dendl K, Finck R, Giesel FL, et al. FAP imaging in rare cancer entities-first clinical experience in a broad spectrum of malignancies. Eur J Nucl Med Mol Imaging. 2021. PMID: 34342669. doi:10.1007/s00259-021-05488-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。